中超控股(002471) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥1,590,712,175.51, a decrease of 1.36% compared to the same period last year[5] - Net profit attributable to shareholders was ¥10,975,226.04, an increase of 1,205.42% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥5,812,604.19, up 661.27% compared to the previous year[5] - Total operating revenue for Q3 2022 was CNY 4,204,561,737.72, a slight increase from CNY 4,184,222,764.32 in Q3 2021, representing a growth of approximately 0.4%[22] - Total operating costs for Q3 2022 were CNY 4,213,889,867.40, compared to CNY 4,194,570,987.10 in the same period last year, indicating an increase of about 0.5%[22] - The net loss for Q3 2022 was CNY 30,761,928.15, an improvement from a net loss of CNY 33,277,743.71 in Q3 2021, reflecting a reduction in losses of approximately 4.5%[23] - The company reported an operating profit of CNY -31,682,544.22 for Q3 2022, an improvement from CNY -35,014,195.13 in Q3 2021, indicating a reduction in operating losses of approximately 9.5%[22] Cash Flow - Cash flow from operating activities reached ¥217,654,740.92, a significant increase of 705.48% year-to-date[5] - The net cash flow from operating activities was CNY 217,654,740.92, a significant recovery from a negative cash flow of CNY -35,947,260.00 in the same period last year[26] - The cash received from sales and services amounted to CNY 4,676,961,774.46, an increase from CNY 3,813,575,817.77 in the previous year, representing a growth of approximately 22.7%[26] - The cash inflow from investment activities totaled CNY 97,848,314.78, compared to CNY 49,562,638.25 in the previous year, indicating an increase of about 97.5%[26] - The net cash flow from investment activities was CNY 71,655,812.09, a turnaround from a negative cash flow of CNY -79,005,857.64 in the same quarter last year[26] - The total cash inflow from financing activities reached CNY 2,660,879,275.70, up from CNY 1,754,474,086.97, marking an increase of approximately 51.5%[27] - The net cash flow from financing activities was CNY -268,616,174.25, worsening from CNY -203,415,906.02 in the previous year[27] - The cash and cash equivalents at the end of the period were CNY 45,769,106.65, compared to CNY 24,071,101.87 at the end of the same period last year, reflecting an increase of about 90.2%[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,955,124,539.17, reflecting a growth of 4.48% from the end of the previous year[5] - As of September 30, 2022, total assets amounted to CNY 5,955,124,539.17, an increase from CNY 5,699,912,897.71 at the beginning of the year[19] - The company reported a total of CNY 434,037,263.77 in other equity instrument investments, up from CNY 423,314,950.87[19] - The company's total liabilities increased to CNY 4,566,017,394.90 in Q3 2022 from CNY 4,288,348,839.25 in Q3 2021, marking an increase of about 6.5%[22] - The total equity attributable to shareholders of the parent company decreased to CNY 1,353,335,528.75 from CNY 1,371,451,594.64 year-on-year, a decline of approximately 1.3%[22] Inventory and Investments - The balance of inventory increased by ¥194,538,967.95, representing a growth of 35.01% due to an increase in products and inventory[9] - The balance of construction in progress rose by ¥5,530,996.81, an increase of 47.46% attributed to workshop renovations and production line updates[10] - The company reported an increase in investment income of ¥6,509,846.36, a growth of 132.75% year-on-year[11] - The balance of contract liabilities increased by ¥70,159,862.68, reflecting a growth of 54.36% due to increased advance payments[10] Shareholder and Legal Matters - The company has a significant shareholder, Jiangsu Zhongchao Investment Group Co., Ltd., holding 17.39% of shares, with 220,444,030 shares pledged[15] - The company is involved in ongoing litigation with a total amount of CNY 14.63 billion related to guarantees made by a former executive[16] Research and Development - Research and development expenses for Q3 2022 were CNY 144,834,601.67, down from CNY 151,275,860.86 in Q3 2021, representing a decrease of about 4.2%[22] Miscellaneous - The company did not conduct an audit for the third quarter report[28] - The report was released by the board of directors on October 28, 2022[29] - The company has not disclosed any new product launches or technological advancements in the current report, suggesting a focus on existing operations[24] - Future outlook and guidance were not explicitly mentioned in the provided documents, indicating a potential area for further clarification in future communications[24]